Concert AI - About the company
Concert AI is a series C company based in Boston (United States), founded in 2018 by Romesh Wadhwani. It operates as a Provider of AI and real-world data solutions for life sciences. Concert AI has raised $300M in funding from Sixth Street and Declaration Partners, with a current valuation of $1.9B. The company has 666 active competitors, including 71 funded and 79 that have exited. Its top competitors include companies like Novotech, H1 and Dedalus.
Sectors and market segments that Concert AI operate in
Concert AI serves in the HealthTech, Life Sciences market segments.The primary business model of Concert AI are:Company Details
Provider of AI and real-world data solutions for life sciences. The company delivers regulatory and research solutions, precision suites, and commercial solutions. It also offers clinical development tools and cancer care solutions. The company's offerings include advanced visualization and AI-driven automation for medical imaging.
- Website
- www.concertai.com/
- Social
- Email ID
- *****@concertai.com
- Registered Address
- Boston, Massachusetts
Key Metrics
Founded Year
2018
Location
Boston, United States
Stage
Series C
Total Funding
$300M in 2 rounds
Latest Funding Round
Post Money Valuation
$1.9B as on Mar 29, 2022
Investors
Ranked
4th among 666 active competitors
Employee Count
860 as on Jul 31, 2026
Investment & Acquisitions
Legal entities associated with Concert AI
Concert AI is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CONCERTAI LLC CIN: 32090029342 , United States, Active | - | - | - | |
CONCERTO HEALTHAI SOLUTIONS CIN: 822784254 , United States, Active | Dec 31, 1999 | - | 410 (As on Dec 31, 2024) | - |
Sign up to download Concert AI's company profile
Concert AI's funding and investors
Concert AI has raised a total funding of $300M over 2 rounds. Its first funding round was on Jan 13, 2020. Its latest funding round was a Series C round on Mar 29, 2022 for $150M. 1 investor participated in its latest round. Concert AI has 6 institutional investors.
Here is the list of recent funding rounds of Concert AI:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 29, 2022 | $150M | Series C | $1.9B | - | - | |
Jan 13, 2020 | $150M | Series B | - | - |
Access funding benchmarks and valuations. Sign up today!View details of Concert AI's funding rounds and investors
Concert AI's founders and board of directors
Founder? Claim ProfileThe founders of Concert AI is Romesh Wadhwani.
Here are the details of Concert AI's key team members:
- Romesh Wadhwani: Former Founder of Concert AI and founder of 5 other companies, including Wadhwani Foundation, Wadhwani AI and STG Partners.
View details of Concert AI's Founder profiles and Board Members
Concert AI's employee count trend
Concert AI has 860 employees as of Jul 26. Here is Concert AI's employee count trend over the years:
Uncover Concert AI's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Concert AI's Competitors and alternates
Top competitors of Concert AI include Novotech, H1 and Dedalus. Here is the list of Top 10 competitors of Concert AI, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of clinical research services across all trial phases and therapeutic areas | $255M | 68/100 | ||
2nd |  H1 2017, New York City (United States), Series C | Provider of medical affair services for biopharma and medical device industry | $361M | 65/100 | |
3rd | Provider of advanced software solutions that enhance healthcare interoperability | $26.9M | 64/100 | ||
4th |  Concert AI 2018, Boston (United States), Series C | Provider of AI and real-world data solutions for life sciences | $300M | 64/100 | |
5th | Developer of AI foundation model to transform biological research | $76M | 63/100 | ||
6th | Dotmatics 2005, Bishop s Stortford (United Kingdom), Acquired | AI powered scientific data management and workflow automation solutions | $11.3M | 61/100 | |
7th |  Greenlight Guru 2013, Indianapolis (United States), Series A | Developer of quality management system software for the medical device industry | $121M | 61/100 | |
8th | Provider of pharmacy management services and software for stock management for patients and pharmacies | $95.3M | 60/100 | ||
9th | MasterControl 1994, Salt Lake City (United States), Late Stage | Developer of software for quality, manufacturing, and asset management solutions | $150M | 59/100 | |
10th |  Health Gorilla 2014, Coral Gables (United States), Series C | Provider of healthcare information network platform to access patient data | $80M | 58/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Concert AI's competitors? Click here to see the top ones
Concert AI's Investments and acquisitions
Concert AI has acquired CancerLinQ. Concert AI has not made any investments as of now.Reports related to Concert AI
Here is the latest report on Concert AI's sector:
News related to Concert AI
Filter this listMedia has covered Concert AI for a total of 11 events in the last 1 year, 6 of them have been about company updates and 3 about people movement.
•
ConcertAI Enhances CancerLinQ Suite with AI-Driven Trial Matching and Patient InsightsBusiness Wire•May 28, 2026•Concert AI
•
ConcertAI Appoints Shawn W. Bates as General Manager, Commercial SolutionsBusiness Wire•May 12, 2026•Concert AI
•
•
•
ConcertAI Launches ACT Platform to Automate Clinical Trials Using Agentic AIHIT Consultant•Feb 02, 2026•Concert AI
•
ConcertAI and Foundation Medicine Unveil Large Oncology DatasetHIT Consultant•Jan 15, 2026•Concert AI, Foundation Medicine
•
•
•
•
Casey Graves Joins ConcertAI as General Manager, Clinical SolutionsBusiness Wire•Sep 11, 2025•Concert AI
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Concert AI
Explore our recently published companies
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company
